RxDoctor Payments Data

Claudia Wong, NP

Nurse Practitioner · Santa Monica, CANPI 1003129925

Payments from drug & device makers

$4,920in general payments, 2019–2025

Across 161 payments — averaging $30.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • UCB, Inc.$806
  • Lilly USA, LLC$364
  • Acadia Pharmaceuticals Inc$344
  • Neurocrine Biosciences, Inc.$338
  • CSL Behring$312
  • Biogen$298
  • plus $2K from 25 others

What the payments were for

  • Food & beverage$4,920100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,920 in reported general payments places this provider in the 90th percentile of 6,779 nurse practitioner providers in California.

See all nurse practitioner providers in California

Medicare billing

Part B allowed, 2024
$56,073
Medicare patients
131
Services billed
429

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Memantine Hcl ErMemantine Hcl192$23,396
Rivastigmine15$4,666
Memantine Hcl105$4,498
Donepezil Hcl172$2,256
Mirtazapine17$727
Escitalopram Oxalate57$591
Quetiapine Fumarate35$505
Trazodone Hcl14$222

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Santa Monica

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →